Unclassified cardiomyopathy in a geriatric cat.
A 15-year-old, neutered male, domestic shorthair presented with dyspnea. Unclassified cardiomyopathy was diagnosed. Treatment resulted in a profound bradycardia, which was attributed to the administration of a beta-adrenergic blocker. The pathogenesis of unclassified cardiomyopathy is discussed and the side effects of beta-adrenergic blockers and angiotensin converting enzyme inhibitors are reviewed.
Wolfson
Rachel
R
Ontario Veterinary College, University of Guelph, Guelph, Ontario.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D000818:Animals; D001262:Atenolol / Q000009:adverse effects / Q000627:therapeutic use; D001919:Bradycardia / Q000139:chemically induced / Q000662:veterinary; D009202:Cardiomyopathies / Q000175:diagnosis / Q000188:drug therapy / Q000662:veterinary*; D002371:Cat Diseases / Q000175:diagnosis* / Q000188:drug therapy; D002415:Cats; D004417:Dyspnea / Q000209:etiology / Q000662:veterinary; D004656:Enalapril / Q000009:adverse effects / Q000627:therapeutic use; D007022:Hypotension / Q000139:chemically induced / Q000662:veterinary; D008297:Male
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D001262:Atenolol; D004656:Enalapril